Heart Failure

Heart failure is one of the most common causes of death. Ageing of the population and novel treatment strategies prolonging the lives of cardiac patients led to an increase in the incidence of heart failure. Despite improved treatments the mortality rate in patients with heart failure is very high. Early diagnosis is critically important, as early treatment of the disease gives the best possible results.

News & events

13-12-2013 ACS Biomarker accelerates biomarker validation in large scale heart failure patient cohorts
Molecular diagnostics frontrunner strengthens R&D capacity and opens new lab in Amsterdam

 

Today, 13th December, marks the opening of ACS Biomarker BV’s new state-of-the-art biomarker laboratory. The lab is specifically equipped for the rapid validation of cardiovascular disease diagnostics. ACS Biomarker collaborates with leading European and Dutch research consortia in large-scale patient studies. The new lab facilitates analysing biomarkers in thousands of patient samples in a high-throughput setting. This lab and the world-class collaborations position ACS Biomarker on the forefront of molecular diagnostics in the cardiovascular field. The lead product in development is a single diagnostic and prognostic multi-biomarker test for heart failure.